Skip to main content
. 2021 Jun 25;12:714348. doi: 10.3389/fendo.2021.714348

Figure 1.

Figure 1

The expected benefits of non-invasive β-cell mass (BCM) evaluation. Loss of BCM has a central role in the onset and progression of type 2 diabetes mellitus. The establishment of non-invasive BCM evaluation methods will open the door to elucidating and understanding the pathophysiology of diabetes, the evaluation of therapeutic efficacies aimed at preserving and restoring BCM, the implementation of personalized diabetes management based on individual BCM, and drug development targeting BCM preservation and restoration.